Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Equity
$68.465
−$0.645 · -0.93%
· Aug 24, 12:08 PM ET
$68.465
Regular session−$0.645 · -0.93%
· Aug 24, 12:08 PM ET
$68.46
−$0.65 · -0.94%
Regular session · ET · Market data may be delayed.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Fund assets
236.37M USD
Expense ratio
0.50%
NAV
$69.01
Average volume
39.01K
Volume
14.69K
Day range
$67.36 – $68.97
52-week range
$34.343 – $70.85
Previous close
$69.11
Price change
1 day
-0.93%
1 month
+7.36%
3 months
+28.45%
Year to date
+33.67%
1 year
+99.20%
3 years
+133.67%
5 years
+52.21%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 24, 2026.
Portfolio composition
Fund income
Dec 19, 2024
Annual
Dec 19, 2024
Dec 26, 2024
$1.1735
Dec 21, 2023
Annual
Dec 22, 2023
Dec 27, 2023
$0.0711
Dec 19, 2019
Annual
Dec 20, 2019
Dec 27, 2019
$0.0159
Dec 20, 2018
Annual
Dec 21, 2018
Dec 27, 2018
$0.7841
Dec 21, 2017
Annual
Dec 22, 2017
Dec 28, 2017
$0.5795
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
